Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects [Phase 1]
This Phase 1 pharmacokinetic study evaluated BIA 9-1067 and its metabolites in healthy elderly and healthy young male subjects; results have…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. [Phase 3]
Phase 3 trial evaluated the efficacy and safety of BIA 9-1067 in idiopathic Parkinson's disease; results were posted in January 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067 [Phase 2]
A Phase 2 study evaluated tolerability and the effects of three single-dose regimens of BIA 9-1067 in Parkinson's disease, with results post…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease [Phase 1, Phase 2]
This document summarizes a completed safety and tolerability study of intracerebroventricular administration of sNN0031 in Parkinson's disea…
-
FDA approval · 2015-01-09FDA Approved: DUOPA — Original Application (AbbVie Inc.)
FDA approved DUOPA (carbidopa and levodopa) from AbbVie under its original application, a gel-delivery formulation for advanced Parkinson's …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules [Phase 1]
Phase 1 comparative bioavailability study of BIA 9-1067 25 mg capsules in Parkinson's disease; the study has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067 [Phase 1]
Phase 1 study of BIA 9-1067 in Parkinson's disease evaluating tolerability, pharmacokinetics and pharmacodynamics completed with results pos…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites [Phase 1]
Phase 1 absorption, distribution, metabolism, and excretion study of [14C]-labeled BIA 9-1067 and metabolites with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of BIA 9-1067 in idiopathic Parkinson's disease patients with wearing-off; results…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients [Phase 2]
This document reports the completion and posting of results for a Phase 2 multicenter trial in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects [Phase 1]
Phase 1 single ascending dose study of BIA 9-1067 in healthy male subjects; Parkinson disease listed as a condition, with results posted in …
-
CLINICAL_TRIALS withdrawal · 2015-01-08Clinical Trial Update: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) [Phase 1]
A Phase 1 single-dose pharmacokinetics study of SCH 900800 in Parkinson's disease patients treated with L-DOPA was withdrawn.
-
FDA approval · 2015-01-07FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s original application for a carbidopa and levodopa product to treat Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China [Phase 3]
Phase 3 trial update reporting results of rasagiline in early Parkinson's disease patients in China who have not been treated with levodopa.
-
CLINICAL_TRIALS research · 2014-12-18Clinical Trial Update: Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease [Phase 2, Phase 3]
This clinical trial update reports on Vitamin B12 status and response to supplementation in Parkinson's disease in a Phase 2/Phase 3 study; …
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Cognitive Training in Parkinson's Disease [NA]
A clinical trial testing cognitive training for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effect of Opicapone at Steady State on Warfarin Pharmacokinetics [Phase 1]
This Phase 1 trial evaluates whether steady-state opicapone alters the pharmacokinetics of warfarin in individuals with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: PET Study of Non-Motor Symptoms of Parkinson Disease
This clinical trial update reports a completed PET imaging study focused on non-motor symptoms in Parkinson disease. The study, sponsored by…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain [Phase 4]
Phase 4 study evaluating rotigotine for pain related to Parkinson's disease; results were posted after completion in 2014.
-
FDA approval · 2014-11-26FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for bromocriptine mesylate submitted by ANI Pharmaceuticals, Inc. This action updates the regula…
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
A VA-sponsored study (Study 1) completed and posted results on developing objective measures for Levodopa-induced dyskinesia in Parkinson's …
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: The ParkCycle Study: Aerobic Exercise in PD [NA]
The ParkCycle Study evaluated aerobic exercise in Parkinson's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease
The study evaluated a biomarker related to the gastrointestinal tract for diagnosing Parkinson's disease. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease [Phase 1]
This is a Phase 1 clinical trial update evaluating relaxation guided imagery as a treatment for pain in Parkinson's disease. The current sta…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Coping With Depression in Parkinson's Disease [NA]
A completed clinical trial evaluating coping strategies for depression in Parkinson's disease has posted results in November 2014.